期刊文献+

高危型人乳头瘤病毒DNA载量与子宫颈上皮内瘤变关系的探讨 被引量:1

下载PDF
导出
摘要 目的探讨高危型人乳头瘤病毒(HR-HPV)感染与宫颈上皮内瘤变(CIN)的关系。方法采用第二代杂交捕获方法 (HC2)和宫颈液基细胞学检测1 500例妇女HR-HPVDNA和宫颈细胞学,对有指征的妇女行阴道镜下活检。比较不同病变患者中高危型HR-HPV的感染率,分析病毒负荷量与CIN的关系。结果 CIN1、CIN2和CIN3中HR-HPV感染率分别为58.57%(41/70)、87.50%(42/48)、93.30%(24/26),三者比较,差异有统计学意义(P<0.05)。CIN1患者HR-HPV载量低于CIN2和CIN3(P<0.05),但CIN2、CIN3患者HR-HPV病毒载量比较,差异无统计学意义(P>0.05)。结论 HR-HPV感染率随CIN病变程度的加重而增加,较高的的HR-HPV病毒载量与高度CIN密切相关。
出处 《中国妇产科临床杂志》 2013年第6期542-543,共2页 Chinese Journal of Clinical Obstetrics and Gynecology
  • 相关文献

参考文献7

二级参考文献27

  • 1Bosch FX,Lorincz A,Munoz N,et al.The causal relation between human papillomavirus and cervical cancer.J Clin Pathol,2002,55(4):244-265. 被引量:1
  • 2Molano M,Posso H,Weiderpass E,et al.Prevalence and determinants of HPV infection among Colombian women with normal cytology.Br J Cancer,2002,87(3):324-333. 被引量:1
  • 3Pham TH,Nguyen TH,Herrero R,et al.Human papillomavirus infection among women in South and North Vietnam.Int J Cancer,2003,104(2):213-220. 被引量:1
  • 4Thomas DB,Qin Q,Kuypers J,et al.Human papillomaviruses and cervical cancer in Bangkok,Ⅱ:risk factors for in situ and invasive squamous cell cervical carcinomas.Am J Epidemiol,2001,153(8):732-739. 被引量:1
  • 5Cuzik J.HPV testing in cervical screening.JAMA,2000,283(1):108-109. 被引量:1
  • 6Schiffiman M,Herrero R,Hidesheim A,et al.HPV DNA testing in cervical cancer screening:results from woman in a high-risk Province of Costa Rica.JAMA,2000,283(1):87-93. 被引量:1
  • 7Ledger W J,Jeremias J,Wit kin SS,et al.Testing for highrisk human papilloma virus types will become a standard of clinical care.Am J Obstet Gynecol,2000,182(4):860-865. 被引量:1
  • 8Wright TC,Denny L,Kuhul,et al.HPV DNA testing of selfcollected vaginal samples compared with cytologic screening to detect cervical cancer.JAMA,2000,283(1):81-86 被引量:1
  • 9Belinson J,Qiao YL,Pretorius R,et al.Prevalence of cervical cancer and feasibility of screening in rural China:a pilot study for the Shaanxi province cervical cancer screening study.Int J Gynecol Cancer,1999,9 (5):411-417. 被引量:1
  • 10Petry KU,Menton S,Menton M,et al.Inclusion of HPV testing in routine cervical cancer screening for women above 29years in Germany:results for 8466 patients.Br J Cancer,2003,88(10):1570-1577. 被引量:1

共引文献80

同被引文献14

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer Clin, 2011, 61.. 69-90. 被引量:1
  • 2Calil LN, Edelweiss MI, Meurer L, et al. P16ink4a and Ki-67 expression in normal, dysplastic and neoplastic uterine cervical epithelium and human papillomavirus (HPV) infection. Pathol ResPract, 2014, 210: 482-487. 被引量:1
  • 3Jaisamrarn U, Castellsagu6 X, Garlands SM, etal. Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA Study. PLoSOne, 2013, 8: e9260. 被引量:1
  • 4Kitchener HC, Canfell K, Gilham C, et al. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow- up of the ARTISTIC randomized trial cohort through three screening rounds. Health Technol Assess, 2014, 18.. 1-196. 被引量:1
  • 5Shukla S, Mahata S, Shishodia G, et al. Physical state & copy number of high risk human papillomavirus type 16 DNA in progression of cervical cancer. Indian J Med Res, 2014, 139: 531-543. 被引量:1
  • 6Del Rio-Ospina L, Soto-De Leon SC, Camargo M, et al. The DNA load of six high-risk human papillomavirus types and its association with cervical lesions. BMC Cancer, 2015, 15.. 100-111. 被引量:1
  • 7Manawapat A, Stubenrauch F, Russ R, et al. Physical state and viral load as predictive biomarkers for persistence and progression of HPV16-positive cervical lesions: results from a population based long-term prospective cohort study. Am J CancerRes, 2012, 2: 192-203. 被引量:1
  • 8Sari Aslani F, Safaei A, Pourjabali M, et al. Evaluation of Ki-67, p16 and CK17 Markers in Differentiating Cervical Intraepithelial Neoplasia and Benign Lesions. Iran J Med Sci, 2013, 38: 15-21. 被引量:1
  • 9Zhang J, Li S, Yan Q, Chen X, et al. Interferon-blnduced microRNA-129-5pDown-Regulates HPV-18 E6 and E7 Viral. Gene Expression by Targeting SP1 in Cervical Cancer Cells. PLoSONE, 2013, g: 1-9. 被引量:1
  • 10Nishio S, Fujii T, Nishio H, et al. p16n~K4~ immunohistochemistry is a promising biomarker to predict the outcome of low grade cervical intraepithelial neoplasia: comparison study with HPV genotyping. J Gynecol Oncol, 2013, 24: 215-221. 被引量:1

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部